Lebanese Interhospital Program to Track Pneumococcal Bacteria Causing Serious Infections in All Ages

What this Trial Is About

Researchers are studying invasive pneumococcal disease caused by the bacterium Streptococcus pneumoniae, which can lead to serious infections like meningitis, pneumonia, and bloodstream infections in both children and adults. The study aims to identify the different serotypes of this bacterium causing disease in Lebanon and to understand their sensitivity to various antibiotics. This information will help assess the usefulness of current pneumococcal vaccines in preventing these infections and will be shared with healthcare providers and the Ministry of Health in Lebanon. This observational study collects bacterial samples from blood, cerebrospinal fluid, and other sterile body fluids from patients of all ages admitted to hospitals across Lebanon with invasive pneumococcal infections. These samples are analyzed to determine the types of pneumococcal bacteria present and their antibiotic resistance patterns. The study does not involve administering treatments or interventions but focuses on gathering important data over time. Participants contribute by providing bacterial isolates from confirmed infections during their hospital stay. Researchers will monitor the prevalence of pneumococcal serotypes yearly and study their antibiotic sensitivity. The study involves reviewing these samples and sharing findings with medical professionals to improve prevention strategies. This long-term program started in 2005 and will continue through 2030, with ongoing collection and analysis of samples to better understand pneumococcal disease in Lebanon.

Lebanese Interhospital Pneumococcal Surveillance Program